A man who is a doctor and a husband to a woman who is also a doctor has created a penis enlarging medication to help him with erectile dysfunction, according to a new study.

A study in the Journal of Sexual Medicine showed that in men over the age of 65 who take the pills, they experience fewer problems with erections, according the American Journal of Otorhinolaryngology-Head and Neck Surgery.

The results were reported in the journal, “A novel phytocannabinoid for phimosis relief: a double-blind, randomized, double-dose study.”

The researchers said the drug is named DMT-10 and is available through pharmacies and through online stores.

It’s not known if the drug would be effective in treating erectile disorder in older men.

The researchers in the study said that although the drug was developed in the 1950s, it wasn’t tested for use in people over 65 for about 30 years before it was approved for use by the U.S. Food and Drug Administration.

The drug was approved in 2009 for the treatment of phimotic disorders, according a spokesman for the U,S.

Drug Enforcement Administration.

Dr. William A. Hoeppner, chief of the division of sexual medicine at the Mayo Clinic, said that in the U., people over age 65 are more likely to use medication to treat phimos.

“They’re the ones who tend to use it more than younger people,” he said.

Hoeppener said the study found that men who take DMT10 have more problems with erection and less pleasure in their sexual lives.

“This is a pill that is very effective for phimposis,” he explained.

“We can have the erectile function we need without the problem of phimpotism.”

Hoeppe said that even though there are some limitations with DMT 10, he said that the medication could help men to reduce the risk of erectile disease.HOEPPNER: There are some side effects with this medication, but that’s the point.

And we want to avoid side effects that are not going to be beneficial.

And in this study, the side effects were less than we’re concerned about.

We don’t want to be like the drug companies, where we’re not concerned about side effects.

It’s a big benefit.

The study authors said the new treatment could be a valuable adjunct to male aging and the risk factors that can lead to erectile dysfunctions.

They also noted that it could be used as a preventive measure to reduce erectile problems.

“There are a lot of things that go into erectile disorders that are caused by things like age, and the older you get, the more of those things are going to occur,” said Dr. John R. DeLuca, chairman of the department of medicine at Johns Hopkins University.

“So there are probably more things that you can do to reduce your risk of problems like this.”

Dr. Hoteppner said the company is looking to expand its clinical studies in older patients.

“We would like to expand into men with erectiles that have been untreated,” he added.

The new drug is also being studied in mice, Dr. Hodeppner noted.